Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
Andreas Agathangelidis,
Viktor Ljungström,
Lydia Scarfò,
Claudia Fazi,
Maria Gounari,
Tatjana Pandzic,
Lesley-Ann Sutton,
Kostas Stamatopoulos,
Giovanni Tonon,
Richard Rosenquist,
Paolo Ghia
Affiliations
Andreas Agathangelidis
Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy
Viktor Ljungström
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Lydia Scarfò
Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy
Claudia Fazi
Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy
Maria Gounari
Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy;Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Tatjana Pandzic
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Lesley-Ann Sutton
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Kostas Stamatopoulos
Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece
Giovanni Tonon
Functional Genomics of Cancer Unit, Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele, Milan, Italy
Richard Rosenquist
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Paolo Ghia
Strategic Research Program on CLL and B-cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy
Despite the recent discovery of recurrent driver mutations in chronic lymphocytic leukemia, the genetic factors involved in disease onset remain largely unknown. To address this issue, we performed whole-genome sequencing in 11 individuals with monoclonal B- cell lymphocytosis, both of the low-count and high-count subtypes, and 5 patients with ultra-stable chronic lymphocytic leukemia (>10 years without progression from initial diagnosis). All three entities were indistinguishable at the genomic level exhibiting low genomic complexity and similar types of somatic mutations. Exonic mutations were not frequently identified in putative chronic lymphocytic leukemia driver genes in all settings, including low-count monoclonal B-cell lymphocytosis. To corroborate these findings, we also performed deep sequencing in 11 known frequently mutated genes in an extended cohort of 28 monoclonal B-cell lymphocytosis/chronic lymphocytic leukemia cases. Interestingly, shared mutations were detected between clonal B cells and paired polymorphonuclear cells, strengthening the notion that at least a fraction of somatic mutations may occur before disease onset, likely at the hematopoietic stem cell level. Finally, we identified previously unreported non-coding variants targeting pathways relevant to B-cell and chronic lymphocytic leukemia development, likely associated with the acquisition of the characteristic neoplastic phenotype typical of both monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.